Academic Publication Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
Correlated Market Trend: Backpressure
Bridging academia to market: The 60-day public search velocity mapping directly to the core technology of this paper. Dashed line represents 7-day moving average.
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study
Abstract Background The triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride-density lipoprotein cholesterol ratio (TG/HDL-C) are substi...
Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury
ImportanceBlood transfusions are commonly administered to patients with acute brain injury. The optimal hemoglobin transfusion threshold is uncertain in this patient population.ObjectiveTo assess t...
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
No description provided.
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease...
No blood pressure report
I don’t understand the report., my heart rate says 20/100 on the report. My blood pressure is140/102 it’s high. My pulse is 106 (normal pulse is 60-100 BPM) I will unsubscribe to this ridiculous app.
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial'?
This literature focuses on:
Which startups are commercializing the technology behind Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial?
Products like Blood Sugar Journal are bringing this to market. Their focus is: AI-powered diabetes tracking for the modern era. .
What other academic literature is closely related to 'Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial'?
Yes, highly correlated activity was mapped. An entry titled 'Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study' discusses this: Abstract Background The triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride-density l...
Are there any mobile apps on the App Store related to 'Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial'?
Yes, highly correlated activity was mapped. An entry titled 'No blood pressure report' discusses this: I don’t understand the report., my heart rate says 20/100 on the report. My blood pressure is140/102 it’s high. My pulse is 106 (normal pulse is 60...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
Product HuntBlood Sugar Journal
-
Product HuntMito Health
SaaS Metrics